For research use only. Not for therapeutic Use.
Hydroxy-PEG4-(CH2)2-Boc(Cat No.:I016722) is an uncleavable linker used in the synthesis of antibody-drug conjugates (ADCs) and PROTACs (Proteolysis Targeting Chimeras). It is derived from compound 191 in patent WO2004008101A2. The linker consists of a hydroxy-PEG4 spacer connected to a (CH2)2-Boc moiety. In ADCs, this linker enables the conjugation of drugs to antibodies, facilitating targeted drug delivery. As a PROTAC linker, it plays a crucial role in bridging the target protein and the E3 ligase, leading to selective protein degradation. Hydroxy-PEG4-(CH2)2-Boc offers versatility and stability in the development of novel therapeutics targeting cancer and other diseases.
Catalog Number | I016722 |
CAS Number | 518044-32-1 |
Molecular Formula | C₁₅H₃₀O₇ |
Purity | ≥95% |
Target | PROTAC |
Storage | 2-8°C |
IUPAC Name | tert-butyl 3-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]propanoate |
InChI | InChI=1S/C15H30O7/c1-15(2,3)22-14(17)4-6-18-8-10-20-12-13-21-11-9-19-7-5-16/h16H,4-13H2,1-3H3 |
InChIKey | FJRDXEGYAVAMLB-UHFFFAOYSA-N |
SMILES | CC(C)(C)OC(=O)CCOCCOCCOCCOCCO |
Reference | [1]. Qingqi Chen,et al. The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates. Patent WO2004008101A2. |